Satagopan Jaya M, Iasonos Alexia, Kanik Joseph G
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Data Brief. 2017 May 5;12:667-675. doi: 10.1016/j.dib.2017.05.005. eCollection 2017 Jun.
The data presented in this article are related to the research article entitled "Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale" (Satagopan and Iasonos, 2015) [1]. These data were digitally reconstructed from figures published in Larkin et al. (2015) [2]. This article describes the steps to digitally reconstruct patient-level data on time-to-event outcome and treatment and biomarker groups using published Kaplan-Meier survival curves. The reconstructed data set and the corresponding computer programs are made publicly available to enable further statistical methodology research.
本文所呈现的数据与题为《衡量不同标志物特定亚组的治疗获益差异：结局量表的选择》（Satagopan和Iasonos，2015年）[1]的研究文章相关。这些数据是根据Larkin等人（2015年）[2]发表的图表进行数字重建的。本文描述了使用已发表的Kaplan-Meier生存曲线对事件发生时间结局、治疗和生物标志物组的患者水平数据进行数字重建的步骤。重建后的数据集及相应的计算机程序已公开提供，以促进进一步的统计方法研究。
